tregalizumab   

GtoPdb Ligand ID: 9864

Synonyms: BT-061 | hB-F5
Compound class: Antibody
Comment: Tregalizumab (BT-061) is an anti-CD4 monoclonal antibody that was developed by Biotest Ag as a potential anti-rheumatoid arthritis therapy [4].
Bioactivity Comments
Patent WO2004083247 A1 which claims tregalizumab, does not provide any affinity values for tregalizumab-CD4 binding, but does contain experimental evidence of the antibody's in vitro and in vivo biological effects [4].
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
CD4 Hs Antibody Binding - - - 4
[4]